AI could Offer Warnings about Serious Side Effects of Drug-Drug Interactions

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ damage and even death. Now, researchers at Penn State have developed a machine learning system that may be able to warn doctors and patients about possible negative side effects that might occur when drugs are mixed.

In a study, researchers designed an algorithm that analyzes data on drug-drug interactions listed in reports - compiled by the Food and Drug Administration and other organizations - for use in a possible alert system that would let patients know when a drug combination could prompt dangerous side effects.

"Let's say I'm taking a popular over-the-counter pain reliever and then I'm put on blood pressure medicine, and these medications have an interaction with each other that, in turn, affects my liver," said Soundar Kumara, the Allen E. Pearce and Allen M. Pearce Professor of Industrial Engineering, Penn State. "Essentially, what we have done, in this study, is to collect all of the data on all the diseases related to the liver and see what drugs interact with each other to affect the liver."

Drug-drug interaction problems are significant because patients are frequently prescribed multiple drugs and they take over-the-counter medicine on their own, added Kumara, who also is an affiliate of the Institute for CyberScience, which provides supercomputing resources for Penn State researchers.

"This study is of very high importance," said Kumara. "Most patients are not on one single drug. They're on multiple drugs. A study like this is of immense use to these people."

To create the alert system, the researchers relied on an autoencoder model, which is a type of artificial neural network that is loosely designed on how the human brain processes information. Traditionally, computers require labeled data, which means people need to describe the data for the system, to produce results. For drug-drug interactions, it might require programmers to label data from thousands of drugs and millions of different combinations of possible interactions. The autoencoder model, however, is suited for semi-supervised algorithms, which means it can use both data that is labeled by people, and unlabeled data.

The high number of possible adverse drug-drug interactions, which can range from minor to severe, may inadvertently cause doctors and patients to ignore alerts, which the researchers call "alert fatigue." In order to avoid alert fatigue, the researchers identified only interactions that would be considered high priority, such as life-threatening, disability, hospitalization and required intervention.

Kumara said that analyzing how drugs interact is the first step. Further development and refinement of the technology could lead to more precise - and even more personalized - drug interaction alerts.

"The reactions are not independent of these chemicals interacting with each other - that's the second level," said Kumara. "The third level of this is the chemical-to-chemical interactions with the genomic data of the individual patient."

The researchers, who released their findings in the August 2019 issue of Biomedical and Health Informatics, used self-reported data from the FDA Adverse Event Reporting System and information on potentially severe drug-drug interactions from the Office of the National Coordinator for Health Information Technology. They also used information from online databases at DrugBank and Drugs.com. Duplicate reports and reports about non-serious interactions were removed.

The list included about 2,891 drugs, or approximately 110,495 drug combinations. The researchers found a total of 1,740,770 reports on serious health outcomes from drug-drug interactions.

Ning Liu, Cheng-Bang Chen, Soundar Kumara.
Semi-Supervised Learning Algorithm for Identifying High-Priority Drug-Drug Interactions Through Adverse Event Reports.
IEEE Journal of Biomedical and Health Informatics, 2 August 2019. doi: 10.1109/JBHI.2019.2932740.

Most Popular Now

Using Artificial Intelligence to Predict…

Thyroid nodules are small lumps that form within the thyroid gland and are quite common in the general population, with a prevalence as high as 67%. The great majority of...

Bayer Launches LifeHub UK Focused on Art…

Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar of Bayer's global network...

NHS Health Tech Team of the Year Named

A pioneering NHS trust has been recognised at the 2019 HTN Awards for its innovative work using InterSystems technology to help enhance care for hundreds of thousands of patients. North...

Philips and Klinikum Stuttgart Hospital …

Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and German Klinikum Stuttgart hospital, the largest provider in the region, announced they have signed a comprehensive 10-year innovation partnership...

First Entirely Digital Clinical Trial En…

As little as a daily ping on your phone can boost physical activity, researchers from the Stanford University School of Medicine and their collaborators report in a new study. The...

Personalised and Powerful: UK to Lead Ne…

The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56...

Innovations for Tomorrow's Healthcare - …

18 - 21 November 2019, Düsseldorf, Germany. Groundbreaking innovations shape tomorrow's medical progress. At this year's MEDICA, visitors can find out what these exemplary innovations will be like in the here...

SilverCloud Health Marks World Mental He…

More than 300,000 people suffering with mental health disorders such as anxiety and depression have now been treated through innovative digital therapy programmes developed as a result of a partnership...

Siemens Healthineers Launches ACUSON Red…

Siemens Healthineers has launched the ACUSON Redwood, a new ultrasound system built on the company's new platform architecture and features advanced applications for greater clinical confidence, AI-powered tools for smart...

Nuance and Microsoft Partner to Transfor…

Nuance Communications Inc. and Microsoft Corp. have joined forces to help transform healthcare delivery for a more sustainable future. Together, the companies will accelerate the delivery of ambient clinical intelligence...

AI Predicts which Pre-Malignant Breast L…

New research at Case Western Reserve University could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast...

MEDICA 2019 + COMPAMED 2019 Bring in ove…

18 - 21 November 2019, Düsseldorf, Germany. More dynamic, more digital and more networked than ever: the medical industry is taking strides into the future. If you want to be in...